dc.relation.reference | [中 文]
[1] 張智星,「MATLAB 程式設計與應用」,清蔚科技,新竹 市,(2000)
[英 文]
[2] A. Makroglou, Jiaxu Li, Yang Kuang” Mathematical models and software tools for the glucose-insulin regulatory system and diabetes: an overview”Applied Numerical Mathematics vol.56,pp 559–573 (2006)
[3] A. Ackerman, C. Gatewood, J. W. Rosevear, and G. D. Molnar, “Model studies of blood glucose regulation” Bull. Math. Biophys., vol.27, pp. 21-37 (1965)
[4] A. Albisser. “An artificial endocrine pancreas “, Diabetes, vol.23, pp.389-404 (1974).
[5] A. H. Clements, P. H. Chang, and R.W. Meyer, “The development of biostator, a glucose controlled insulin infusion system”, Horm. Metab. Res. vol.9, pp.23-33 (1977)
[6] C. Cobelli, A. Caumo, P. Vicini, J.Z. Jeffrey, A. Angelo, Y. Kevin, M. B. Dennis’ Undermodeling affects minimal model indexes: insights from a two-compartment model’ Am J Physiol Endocrinol Metab.vol. 276,pp.1171-1193, (1999)
[7] C. Cobelli, G. Pacini, G. Toffolo, and L. Sacca ‘Estimation of insulin sensitivity and glucose clearance from minimal model: new insights from labeled IVGTT’ Am J Physiol Endocrinol Metab, pp.E591~E598 (1986)
[8] B. Candas, J. Radziuk, “An adaptive plasma glucose controller based on a nonlinear insulin/glucose model”, IEEE Trans Biomed Eng. vol.41(2) pp.116-24 (1994)
[9] J.F. Casanova Domingo, R. Ruiz, F. Aldana, M. Serrano-Rios,’Adaptation drift suppression in blood glucose self-tuning control”, Artif Organs. Apr ;21(4):272-277 (1991)
[10] F. Chiarelli, S. Tumini, G. Morgese, A.M. Albisser,“Controlled study in diabetic children comparing insulin-dosage adjustment by manual and computer algorithms”, Diabetes Care. Oct; vol.13(10),pp.1080-1084.(1990)
[11] M. E. Fisher,“A semiclosed-loop algorithm for the control of blood glucose levels in diabetics”, IEEE Trans Biomed Eng. Jan; vol.38(1),pp.57-61.(1991)
[12] T. E. Guttinger, M. Morari, “Predicting Multiple Steady States in Equilibrium Reactive Distillation. 1. Analysis of Nonhybrid Systems.” Ind. Eng. Chem. Res., vol.38(4),pp.1633 (1999).
[13] G. Marchetti, M. Barolo, L. Jovanovic, H. Zisser, and Dale E. Seborg, “An Improved PID Switching Control Strategy for Type-1 Diabetes” IEEE EMBS Annual Int. Conf
[14] G. Schlotthauer, G.A. Nicolini, L.G. Gamero, M.E. Torres,” Type-1 Diabetes: Modeling, Identification, Non-linear model predict control” IEEE Trans Biomed Eng. vol.33, pp.2261-2271,(2002)
[15] H. Zisser, L. Jovanovic, F. Doyle, P. Ospina, and C. Owens, “Run–to–run control of meal–related insulin dosing,” Diabetes Technol Ther, vol. 7, no. 1, pp. 48–57,(2005)
[16] Jiaxu Li,Yang Kuang,Clinton C. Mason;” Modeling the glucose–insulin regulatory system and ultradian insulin secretory oscillations with two explicit time delays” Journal of Theoretical Biology.vol.242, pp.722–735 (2006)
[17] S. Kan, H. Onodera, E. Furutani, T. Aung, M. Araki, H. Nishimura, S. Maetani, M. Imamura., ”Novel control system for blood glucose using a model predictive method”, ASAIO J. Nov-Dec;vol.46(6),pp.657-62.(2000)
[18] K.H. Kienitz, T. Yoneyama,“A robust controller for insulin pumps based on H-infinity theory”, IEEE Trans Biomed Eng. vol;40(11),pp.1133 (1993)
[19] L.C. Gatewood, Ackerman E., J. W. Rosevear,, G. D. Molnar, “Test of Mathematical model of the blood-glucose regulatory system”, Comput. Biol. Med., vol.2, pp. 1-14, (1968)
[20] L.C. Gatewood, Ackerman E., J. W. Rosevear,, G. D. Molnar, ” Simulation studies of blood-glucose regulation: Effect of intestinal glucose absorption”. Comput. Biol. Med., vol.2, pp.15-27 (1968)
[21] E. W. Malgorzata, J. C. Ludovic, C. S. Helga, S. Lukas, R.P. Thomas, and R. Hovorka;” Insulin Kinetics in Type-1 Diabetes: Continuous and Bolus Delivery of Rapid Acting Insulin” IEEE. Trans. On Biomedical Enginering, vol.52, No.1, January (2005)
[22] E. F. Michael and L. T. Kok, “Optimal insulin infusion resulting from a mathematical model of blood glucose dynamics. IEEE. Trans. On Biomedical Enginering, vol. 36, no.4. pp.479-486,(1989)
[23] T.F. Pfeiffer, C. Thum, and A.H. Clements, “The artificial beta cell—a continuous control of blood sugar be external regulation of insulin infusion, Horm. Metab. Res. Vol.6, pp. 339-342, (1974)
[24] P. Palazzo, V. Viti, ”A new glucose-clamp algorithm--theoretical considerations and computer simulations”, IEEE Trans Biomed Eng. vol.37(5),pp.535-543 (1990)
[25] R. Bellazzi, G. Nucci, C. Cobelli,“The subcutaneous route to insulin - dependent diabetes therapy”IEEE Eng. Med. Biol. Mag. vol.20(1) pp.54~64. (2001)
[26] G..P. Reboldi, P.D. Home, G.. Calabrese, P.G. Fabietti, Brunetti, P. Massi. M. Benedetti., ‘Time delay compensation for closed-loop insulin delivery systems: a simulation study”, Int J Artif Organs. Jun; vol.14(6),pp.350-358. (1991)
[27] R. Hovorka,“Management of diabetes using adaptive control” Int. J. Adapt. Control Signal Process. vol.9(5), pp.309~325.(2005)
[28] R. Hovorka, F. Shojee-Moradie, P.V. Carroll,” Partitioning glucose distribution/transport, disposal ,and endogenous production during IVGTT ”Am J Physiol Endocrinol Metab vol.282.pp.992-1007,( 2002)
[29] Roman Hovorka, Valentina Canonico, Ludovic J Chassin, Ulrich Haueter, Massimo Massi-Benedetti, Marco Orsini Federici, Thomas R Pieber, Helga C Schaller, Lukas Schaupp, Thomas Vering and Malgorzata EWilinska;” Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes” Physiol. Meas.vol.25,pp.905–920(2004)
[30] R. Hovorka, L. J. Chassin, M. E. Wilinska, V. Canonico, J. A. Akwi, M. O. Federici, M. Massi-Benedetti, I. Hutzli, C. Zaugg, H. Kaufmann, M. Both, T. Vering, H. C. Schaller, L. Schaupp, M. Bodenlenz, T. R. Pieber, Closing the loop: the ADICOL experience, Diabetes Technol Ther vol.6(3),pp.307-318. (2004)
[31] R. Hovorka.”Continuous glucose monitoring and closed-loop systems ” Diabet Med vol.23 pp.1-12.(2006)
[32] R. N. Bergman, C. R. Bowden, C. Cobelli,” The minimal model approach to quanti-cation of factors controlling glucose disposal in man ”in: C. Cobelli, R. N. Bergman (Eds.), Carbohydrate Metabolism, John Wiley & Sons Ltd., Ch. 13, pp. 269-293.(1981)
[33] R. N. Bergman, Finegood, D.T., Ader, M.,” Assessment of insulin sensitivity in vivo ”. Endocr. Rev. 6, 45–86.(1985)
[34] R. N. Bergman,” The minimal model: yesterday, today, and tomorrow, in: The minimal model approach and determinants of glucose tolerance ”, Vol. 7 of Pennington Center Nutrition Series, Louisiana State University Press, Baton Rouge, LA, pp. 3-50.(1997)
[35] R. N. Bergman, “ Pathogenesis and prediction of diabetes mellitus: lessons from integrative physiology “. Irving L. Schwartz Lecture, Mount Sinai J. Med. Vol.60,pp.280–290.(2002)
[36] R. N. Bergman, Finegood, D.T., Kahn, S.E., The evolution of betacell dysfunction and insulin resistance in type 2 diabetes. Eur. J. Clin. Invest.vol. 32 (Suppl. 3), pp.35–45.( 2002)
[37] R. S. Parker, F. J. Doyle III, N. A. Peppas, “The intravenous route to blood glucose control” IEEE Eng. Med. Biol. Mag. vol.20 (1), pp.65~73. (2001)
[38] R. S. Parker, F. J. Doyle, III, N. A. Peppas, “ A model-based algorithm for blood glucose control in type I diabetic patients ” IEEE Trans. Biomed. Eng. vol.46 (2), pp.148-157. (1999)
[39] S.Kirkpatrick, C.D.Gelatt,“M.P.Vecchi. Optimization by Simulated Annealing”. Science 13 May, vol. 220, Number 4598,(1983)
[40] S. M. Lynch, B. W. Bequette, “ Model predictive control of blood glucose in type I diabetics using subcutaneous glucose measurements ” in: Proceedings of the American Control Conference, pp. 4039-4043. (2002)
[41] R.F. Stengel, Optimal Control and Estimation. Dover Publications: New York, (1994) (originally published as Stochastic Optimal Control: Theory and Application. Wiley)
[42] J. Sturis , K.S. Polonsky , E. Mosekilde , E. Van Cauter, Computer model for mechanisms underlying ultradian oscillations of insulin and glucose. Am. J. Physiol. 260, E801–E809.(1991)
[43] T. Yipintsoi, L.C. Gatewood, E. Ackerman, P.L., Spivak, G. D. Molnar, G. W. Rosevear, and F.C. Service, “Mathematical analysis of blood glucose and plasma insulin responses to insulin infusion in healthy and diabetes subjects”, Comput. Biol. Med., vol.3, pp.71-78, (1973)
[44] J. T. Sorensen, “A Physiologic Model of Glucose Metabolism in Man and its Use to Design and Assess Improved Insulin Therapies for Diabetes,” PhD Thesis, Dept. of Chemical Engineering. MIT (1985). | zh_TW |